AURKB and chronic myelogenous leukemia, BCR-ABL1 positive: In JAK2V617F cells, reversine reduced AURKA and AURKB expression/activity and induced DNA damage and apoptosis markers, which was similar to the one observed for AML and CML cell lines21,27.